Contributors
Recent Posts
- Long Term Care Facilities Should Prepare for County Investigations Into COVID Deaths
- OIG Puts Telehealth in its Crosshairs
- Healthcare Providers Must Remain Vigilant with ADA Service Animal Requirements
- The Ten Year Wait is Over: HRSA Releases 340B Dispute Resolution Final Rule
- HHS Final Rules Modernize the Stark Law and Anti-Kickback Statute to Usher in Value-Based Care
- The CDC’s New Definition of “Close Contact”: What You Need To Know
- U.S. Department of Labor Issues Revised Regulations Implementing FFCRA Leaves Following New York Court’s Decision
- Michigan Reinstitutes Pre-COVID Scope of Practice, Licensure, and Liability Standards
- DHHS Issues Terms and Conditions for Relief Funds
- Nursing Home Compliance Under the COVID-19 Microscope
Related Practices
- Ambulatory Care Providers
- Bankruptcy, Insolvency & Creditors' Rights
- Bioethics & End-of-Life Care
- Biotechnology and Life Science
- Cannabis Law
- Government Investigations and Corporate Compliance
- Health Care
- Health Care Administrative Law & Regulatory Appeals
- HIPAA—Health Information Privacy & Security
- Hospitals and Health Care Systems
- Long-Term & Post-Acute Care Providers
- Nonprofits & Tax-Exempt Organizations
- Pharmacies, DEA & Robinson-Patman/340B Drug Programs
- Physicians, Dentists and Non-Physician Practitioners
Related Industries
Showing 1 post by Phyllis Adams.
CARES: Implications for the Healthcare Industry
On March 25, the Senate passed the Coronavirus Aid, Relief, and Economic Security Act (“CARES”). The House is expected to vote on the legislation on March 27, 2020. The following is a summary of the significant provisions impacting the health care industry. Read More ›